Personalized Solutions for Pharma Research & Discovery

Know what data you have, where it sits, and how it should flow.

We run an as-is analysis of current spreadsheets, formats and workflows, surface data gaps and inconsistencies, and design a conceptual to-be data model and end-to-end data-flow framework, agreed with your scientists in alignment workshops and documented ready for digitalization.

A continuous pipeline of digitalization and automation wins, on a 90-day rhythm.

We stand up a value-based delivery factory: each cycle discovers, prioritizes and delivers high-impact use cases as reusable building blocks. You keep final prioritization authority; a quarterly steering reviews the last 90 days and decides the next.

Connect experiments, data and AI to accelerate candidate selection.

We architect and implement a self-learning platform that integrates experiments, data and AI, for example connecting synthetic biology, IVT and immunomodulation, to surface correlations between sequence design and cellular expression and speed up screening.

Trace, access and reuse samples across sites without the hunt.

We concept, design and deliver a digital biorepository, a virtual + physical solution to handle, search and retrieve biosamples securely across sites, with an integrated request → register → store workflow and a FAIR-aligned sample data model.

Buy, build or skip, a vendor-agnostic read on your lab and data stack.

We assess your current tooling against pre-defined criteria and recommend what to buy, build or leave, with a costed view and no SKU of our own to defend.

A self-learning lab platform that connected experiments, data and AI, and lifted early-development candidate output. Discovery acceleration, proven in the lab.

Background

A research organisation expanded rapidly through multiple acquisitions, driven by funding and portfolio diversification. The brief: maximise the value of those acquisitions and integrate the teams without losing momentum on candidate selection.

Solution

Personalized Solutions to structure the integration. The flagship project: an mRNA facility for in-vivo screening to accelerate candidate selection. A self-learning platform connecting synthetic biology, IVT and immunomodulation, surfacing correlations between sequence design and cellular expression.

Results · 12 mo. after engagement

300% increase in early-development candidates vs. the year before. 40% of scientists' time freed for creative work rather than repetitive tasks.

inite's role

inite owned full implementation, project lead, engineering and implementation monitoring. Architected the high-throughput solution. Negotiated with stakeholders to find the best path to the goal.

“inite's strength was to create and implement systems and structures that helped us be more efficient and effective. The ability not to force these structures but align with stakeholders made them a trusted advisor for us.”

COO · Global Biotech Company

Making distributed research samples searchable and FAIR, the data backbone that early discovery runs on.

Background

Cross-site collaboration on bio-sample management, biosamples (cells, proteins, plasmids, antibodies) distributed across multiple locations with no clear structure. Tracing, accessing and collecting the right samples was slow; scientific productivity was capped.

Solution

A global virtual + physical solution to handle, search and retrieve biosamples. Secure cross-site sharing, AI-contextualised digital + physical storage, and an integrated request → register → store workflow.

Results · 12 mo. after engagement

Remote and centralised access to bio samples. Faster data access. Lower experiment time and cost. ~35% efficiency improvement.

inite's role

inite concepted, designed and managed the full DBR implementation across life-science, IT and business domains. Delivered a standardised Bio-Sample Data Model aligned with FAIR principles. Aligned multiple sites and functions on a single workflow.

“Inite positively influenced a change of mindset and supported us to approach the task with fresh thinking. Their approach allowed the team to imagine solutions in an unlimited way rather than being held back by constraints and obstacles.”

Global Process Owner, Biosample Management · Global Pharma Company